Intestinal Dysbiosis, Gut Hyperpermeability and Bacterial Translocation: Missing Links Between Depression, Obesity and Type 2 Diabetes.

Abstract:

:The comorbid prevalence of major depressive disorder (MDD) with obesity and type II diabetes mellitus reflects the existence of a subset of individuals with a complex common pathophysiology and overlapping risk factors. Such comorbid disease presentations imply a number of difficulties, including: decreased treatment responsivity and adherence; altered glycemic control and increased risk of wider medical complications. A number of factors link MDD to metabolic-associated disorders, including: higher rates of shared risk factors such as poor diet and physical inactivity and biological elements including increased inflammation; insulin resistance; oxidative and nitrosative stress; and mitochondrial dysfunction. All of these biological factors have been extensively investigated in the pathophysiology of obesity and type 2 diabetes mellitus as well as MDD. In this review, we aim to: (1) overview the epidemiological links between MDD, obesity and type 2 diabetes mellitus; (2) discuss the role of synergistic neurotoxic effects in MDD comorbid with obesity, and type 2 diabetes mellitus; (3) review evidence of intestinal dysbiosis, leaky gut and increased bacterial translocation, in the pathophysiology of MDD, obesity and type 2 diabetes mellitus; and (4) propose a model in which the gut-brain axis could play a pivotal role in the comorbidity of these disorders.

journal_name

Curr Pharm Des

authors

Slyepchenko A,Maes M,Machado-Vieira R,Anderson G,Solmi M,Sanz Y,Berk M,Köhler CA,Carvalho AF

doi

10.2174/1381612822666160922165706

subject

Has Abstract

pub_date

2016-01-01 00:00:00

pages

6087-6106

issue

40

eissn

1381-6128

issn

1873-4286

pii

CPD-EPUB-78511

journal_volume

22

pub_type

杂志文章,评审
  • Anesthetic cardioprotection in clinical practice from proof-of-concept to clinical applications.

    abstract::In 2007, the American Heart Association (AHA) recommended (class IIa, level of evidence B) in their guidelines on Perioperative Cardiovascular Evaluation and Care for Noncardiac Surgery volatile anesthetics as first choice for general anesthesia in hemodynamically stable patients at risk for myocardial ischemia. This ...

    journal_title:Current pharmaceutical design

    pub_type: 杂志文章,评审

    doi:10.2174/1381612820666140204120829

    authors: Zaugg M,Lucchinetti E,Behmanesh S,Clanachan AS

    更新日期:2014-01-01 00:00:00

  • Effect of SDF-1 α on endogenous mobilized and transplanted stem cells in regeneration after myocardial infarction.

    abstract::Aim of the presented study was to investigate the role of stromal derived factor 1 (SDF-1α) in mobilizing stem cells in combination with endothelial progenitor cell (EPC) transplantation in a regenerative strategy for myocardial infarction therapy in a murine ischemia/reperfusion model. Initially bone marrow was eradi...

    journal_title:Current pharmaceutical design

    pub_type: 杂志文章

    doi:10.2174/13816128113199990443

    authors: Schuh A,Konschalla S,Kroh A,Schober A,Marx N,Sonmez TT,Zenke M,Sasse A,Liehn EA

    更新日期:2014-01-01 00:00:00

  • Interactive endogenous small molecule (gaseous) signaling: implications for teratogenesis.

    abstract::Dioxygen (O2) is an exogenously supplied gas with a number of properties that make it valuable as a biological source of energy and as a result much of life has become dependent on this molecule. Nitric oxide (NO), carbon dioxide (CO) and hydrogen sulfide (H2S) are small molecules that are sometimes in a gaseous state...

    journal_title:Current pharmaceutical design

    pub_type: 杂志文章,评审

    doi:10.2174/138161207782110525

    authors: Fukuto JM,Collins MD

    更新日期:2007-01-01 00:00:00

  • The role of hyperglycaemia and the hypercoagulable state in the pathogenesis of cardiovascular events in diabetes mellitus: implications for hypertension management.

    abstract::Population studies have identified diabetes mellitus as a risk factor for cardiac and vascular events, with a common association with hypertension. Observational studies have consistently demonstrated blood glucose as a continuous cardiovascular risk factor. Experimental studies suggest that elevated blood glucose, th...

    journal_title:Current pharmaceutical design

    pub_type: 杂志文章,评审

    doi:10.2174/138161206776843322

    authors: Lim HS,MacFadyen RJ,Bakris G,Lip GY

    更新日期:2006-01-01 00:00:00

  • Animal models of gastric bleeding induced by dual antiplatelet therapy using aspirin and clopidogrel--prophylactic effect of antiulcer drugs.

    abstract::We set up two models of gastric bleeding in rats using low-dose aspirin (ASA) and the antiplatelet drug clopidogrel, a P2Y₁₂ receptor antagonist, and examined the effect of antiulcer drugs on gastric bleeding and ulcerogenic responses under such conditions. Under urethane anesthesia, two catheters were inserted into t...

    journal_title:Current pharmaceutical design

    pub_type: 杂志文章

    doi:10.2174/13816128113199990418

    authors: Takeuchi K,Izuhara C,Takayama S,Momode T,Kojo M,Hara D,Amagase K

    更新日期:2014-01-01 00:00:00

  • Fibrates and microvascular complications in diabetes--insight from the FIELD study.

    abstract::Fibrates are widely prescribed lipid-lowering drug in the treatment of dyslipidemia. Their main clinical effects, mediated by peroxisome proliferative activated receptor (PPAR) alpha activation, are a moderate reduction in total cholesterol and low-density lipoprotein cholesterol (LDL-C) levels, a marked reduction in ...

    journal_title:Current pharmaceutical design

    pub_type: 杂志文章,评审

    doi:10.2174/138161209787315701

    authors: Ansquer JC,Foucher C,Aubonnet P,Le Malicot K

    更新日期:2009-01-01 00:00:00

  • NLRP3 Inhibitors as Potential Therapeutic Agents for Treatment of Inflammatory Bowel Disease.

    abstract:BACKGROUND:Inflammatory bowel disease (IBD) is a group of intestinal disorders characterised by chronic relapsing inflammation of the small intestine and colon. IBD manifests as either ulcerative colitis or Crohn's disease and increases the risk of developing colorectal cancer. METHODS:Here, we have reviewed current t...

    journal_title:Current pharmaceutical design

    pub_type: 杂志文章,评审

    doi:10.2174/1381612823666170201162414

    authors: Perera AP,Kunde D,Eri R

    更新日期:2017-01-01 00:00:00

  • Adipose tissue macrophages, low grade inflammation and insulin resistance in human obesity.

    abstract::Obesity was first described as a low-grade inflammatory condition more than a decade ago. However, it is only relatively recently that obese individuals have been described with increased macrophage infiltration of adipose tissue, as well as an increase in the number of "M1" or "classically activated" macrophages. Fur...

    journal_title:Current pharmaceutical design

    pub_type: 杂志文章,评审

    doi:10.2174/138161208784246153

    authors: Heilbronn LK,Campbell LV

    更新日期:2008-01-01 00:00:00

  • Can mycobacterial genomics generate novel targets as speed-breakers against the race for drug resistance.

    abstract::The rise of multi-drug resistant and extensively drug resistant M. tuberculosis around the world poses a great threat to human health, and necessitates development of new, effective and inexpensive anti-tubercular agents. The availability of knowledge on molecular biology of M. tuberculosis infection coupled with whol...

    journal_title:Current pharmaceutical design

    pub_type: 杂志文章,评审

    doi:10.2174/1381612819666131118165427

    authors: Chauhan RS,Chanumolu SK,Rout C,Shrivastava R

    更新日期:2014-01-01 00:00:00

  • Traditional Risk Factors are Causally Related to Carotid Intima-Media Thickness Progression: Inferences from Observational Cohort Studies and Interventional Trials.

    abstract::In the present review, associations between traditional vascular risk factors (VRFs) and carotid intimamedial thickness progression (C-IMTp) as well as the effects of therapies for VRFs control on C-IMTp were appraised to infer causality between each VRF and C-IMTp. Cohort studies indicate that smoking, binge drinking...

    journal_title:Current pharmaceutical design

    pub_type: 杂志文章,评审

    doi:10.2174/1381612825666191213120339

    authors: Frigerio B,Werba JP,Amato M,Ravani A,Sansaro D,Coggi D,Vigo L,Tremoli E,Baldassarre D

    更新日期:2020-01-01 00:00:00

  • Recent Advances in Non-Invasive Delivery of Macromolecules using Nanoparticulate Carriers System.

    abstract:BACKGROUND:The drug delivery of macromolecules such as proteins and peptides has become an important area of research and represents the fastest expanding share of the market for human medicines. The most common method for delivering macromolecules is parenterally. However parenteral administration of some therapeutic ...

    journal_title:Current pharmaceutical design

    pub_type: 杂志文章,评审

    doi:10.2174/1381612822666161026163201

    authors: Shadab M,Haque S,Sheshala R,Meng LW,Meka VS,Ali J

    更新日期:2017-01-01 00:00:00

  • The Emerging Roles of the HERC Ubiquitin Ligases in Cancer.

    abstract:BACKGROUND:The HERC family contains six members from HERC1 to HERC6 that are featured with the HECT domains that exerts ubiquitin ligase activity and the RCC1-like domains that are involved in cell cycle regulation. Although identified as early as 1990s, their biological functions are extensively studied in recent year...

    journal_title:Current pharmaceutical design

    pub_type: 杂志文章,评审

    doi:10.2174/1381612824666180528081024

    authors: Mao X,Sethi G,Zhang Z,Wang Q

    更新日期:2018-01-01 00:00:00

  • Developing antiangiogenic peptide drugs for angiogenesis-related diseases.

    abstract::Angiogenesis is regulated by stimulators and inhibitors and involve multiple biological processes including endothelial cell proliferation, migration, cell-cell and cell-matrix adhesion, assembly into tube structures as well as apoptosis. Designing and developing peptides for therapeutic application to inhibit angioge...

    journal_title:Current pharmaceutical design

    pub_type: 杂志文章

    doi:10.2174/138161207781039715

    authors: Sulochana KN,Ge R

    更新日期:2007-01-01 00:00:00

  • Safety Profile of the Newest Antiepileptic Drugs: A Curated Literature Review.

    abstract:BACKGROUND:Despite the introduction of new antiepileptic drugs (AEDs), the quality of life and therapeutic response for patients with epilepsy remain unsatisfactory. In addition, whilst several antiepileptic drugs (AEDs) have been approved and consequently marketed in recent years, little is known about their long-term...

    journal_title:Current pharmaceutical design

    pub_type: 杂志文章,评审

    doi:10.2174/1381612823666170809115429

    authors: Palleria C,Cozza G,Khengar R,Libri V,De Sarro G

    更新日期:2017-01-01 00:00:00

  • Naturally Occurring Plectranthus-derived Diterpenes with Antitumoral Activities.

    abstract::The study of natural sources such as plants, microorganisms and marine organisms has developed interest among the scientific community in recent years for their extensive and diverse chemical composition and consequent biological potential. The search for antitumor compounds is among the lead causes that justify phyto...

    journal_title:Current pharmaceutical design

    pub_type: 杂志文章,评审

    doi:10.2174/1381612825666190115144241

    authors: Garcia C,Teodósio C,Oliveira C,Oliveira C,Díaz-Lanza A,Reis C,Duarte N,Rijo P

    更新日期:2018-01-01 00:00:00

  • The Contribution of Transcriptomics to Biomarker Development in Systemic Vasculitis and SLE.

    abstract::A small but increasing number of gene expression based biomarkers are becoming available for routine clinical use, principally in oncology and transplantation. These underscore the potential of gene expression arrays and RNA sequencing for biomarker development, but this potential has not yet been fully realized and m...

    journal_title:Current pharmaceutical design

    pub_type: 杂志文章,评审

    doi:10.2174/1381612821666150313130256

    authors: Flint SM,McKinney EF,Lyons PA,Smith KG

    更新日期:2015-01-01 00:00:00

  • Pemafibrate Tends to have Better Efficacy in Treating Dyslipidemia than Fenofibrate.

    abstract:AIMS:To compare the efficacy of pemafibrate (PF) and fenofibrate (FF) in treating dyslipidemia. METHODS:A comprehensive search was performed on the public database to identify relevant randomized controlled trials (RCTs), which compared the effects of PF and FF treatment in lipid parameters among patients with dyslipi...

    journal_title:Current pharmaceutical design

    pub_type: meta分析

    doi:10.2174/1381612825666191126102943

    authors: Wang H,Li H,Zhou Y,Liu J,Wang F,Zhao Q

    更新日期:2019-01-01 00:00:00

  • Mitochondrial Dysfunction and Endoplasmic Reticulum Stress in Diabetes.

    abstract::It is generally accepted that mitochondrial dysfunction and endoplasmic reticulum (ER) stress are related to insulin resistance and type 2 diabetes. Mitochondria use substrates from lipid and glucose metabolism in order to generate ATP, and when mitochondrial O2 consumption is decreased due to an altered metabolism th...

    journal_title:Current pharmaceutical design

    pub_type: 杂志文章,评审

    doi:10.2174/1381612822666160209152033

    authors: Rocha M,Diaz-Morales N,Rovira-Llopis S,Escribano-Lopez I,Bañuls C,Hernandez-Mijares A,Diamanti-Kandarakis E,Victor VM

    更新日期:2016-01-01 00:00:00

  • Human papillomavirus (HPV) vaccines as an option for preventing cervical malignancies: (how) effective and safe?

    abstract::We carried out a systematic review of HPV vaccine pre- and post-licensure trials to assess the evidence of their effectiveness and safety. We find that HPV vaccine clinical trials design, and data interpretation of both efficacy and safety outcomes, were largely inadequate. Additionally, we note evidence of selective ...

    journal_title:Current pharmaceutical design

    pub_type: 杂志文章,评审

    doi:

    authors: Tomljenovic L,Spinosa JP,Shaw CA

    更新日期:2013-01-01 00:00:00

  • Lipid-based Nanocarriers for Cancer and Tumor Treatment.

    abstract::Cancer and tumor have been major reasons for numerous deaths in this century across the world. Many strategies have been designed to treat, diagnose, or prevent cancer. The success of chemotherapy largely depends on drug targeting. The advent of nanotechnology has vastly improved drug delivery for targeting and diagno...

    journal_title:Current pharmaceutical design

    pub_type: 杂志文章

    doi:10.2174/1381612826666200720235752

    authors: Ansari MT,Ramlan TA,Jamaluddin NN,Zamri N,Salfi R,Khan A,Sami F,Majeed S,Hasnain MS

    更新日期:2020-01-01 00:00:00

  • Locked nucleic acid holds promise in the treatment of cancer.

    abstract::Providing novel treatments to help cancer patients live longer and have better lives remains one of the biggest challenges of the pharmaceutical industry. Today much is known about the molecular and genetic causes of cancers thus facilitating the development of novel targeted cancer drugs with improved risk-benefit ra...

    journal_title:Current pharmaceutical design

    pub_type: 杂志文章,评审

    doi:10.2174/138161208784246234

    authors: Frieden M,Ørum H

    更新日期:2008-01-01 00:00:00

  • Organotin(IV) Carboxylates as Promising Potential Drug Candidates in the Field of Cancer Chemotherapy.

    abstract::Medicinal inorganic chemistry plays an important role in exploring the properties of metal ions for the designing of new drugs. The field has been stimulated by the success of cis-platin, the world best selling anticancer drug and platinum complexes with reduced toxicity, oral activity and activity against resistant t...

    journal_title:Current pharmaceutical design

    pub_type: 杂志文章,评审

    doi:10.2174/1381612822666160906143249

    authors: Sirajuddin M,Ali S

    更新日期:2016-01-01 00:00:00

  • Nanoparticles and Immune Cells.

    abstract::Nanoparticles have gained ground in several fields. However, it is important to consider their potentially hazardous effects on humans, flora, and fauna. Human exposure to nanomaterials can occur unintentionally in daily life or in industrial settings, and the continuous exposure of the biological components (cells, r...

    journal_title:Current pharmaceutical design

    pub_type: 杂志文章,评审

    doi:10.2174/1381612825666190926161209

    authors: Mitarotonda R,Giorgi E,Desimone MF,De Marzi MC

    更新日期:2019-01-01 00:00:00

  • PCSK9 inhibitors for the management of dyslipidemia in people with Type 2 Diabetes: How low is too low?

    abstract::Diabetic patients are considered as high risk for development of atherosclerotic disease. Cholesterol treatment is of paramount importance in order to optimise cardiovascular outcomes in this subset of patients. Although statins are regarded as the mainstay of treatment, these may not be tolerated or as efficacious as...

    journal_title:Current pharmaceutical design

    pub_type: 杂志文章

    doi:10.2174/1381612826666200617170252

    authors: Felekos I,Karamasis GV,Pavlidis AN

    更新日期:2020-06-17 00:00:00

  • Gene vectors for cytokine expression in vivo.

    abstract::The understanding of cytokine networks and the exploitation of these networks for the treatment of immune and inflammatory diseases as well as cancer depend on in vivo delivery of cytokines. Due to instability of recombinant cytokine proteins, investigators have employed cytokine-encoding gene therapy vectors to induc...

    journal_title:Current pharmaceutical design

    pub_type: 杂志文章,评审

    doi:10.2174/1381612003400551

    authors: Hitt MM,Gauldie J

    更新日期:2000-04-01 00:00:00

  • Dangerous liaisons between beta-amyloid and cholinergic neurotransmission.

    abstract::The review examines the multifaceted interactions between cholinergic transmission and beta-amyloid suggesting a continuum in the action of the peptide that at low concentrations (picomolar-low nanomolar) may directly stimulate nicotinic cholinergic receptor while desensitizing them at increasing concentrations (high ...

    journal_title:Current pharmaceutical design

    pub_type: 杂志文章,评审

    doi:10.2174/13816128113199990503

    authors: Govoni S,Mura E,Preda S,Racchi M,Lanni C,Grilli M,Zappettini S,Salamone A,Olivero G,Pittaluga A,Marchi M

    更新日期:2014-01-01 00:00:00

  • Strontium ranelate in osteoporosis.

    abstract::Strontium ranelate is composed of an organic moiety (ranelic acid) and of two atoms of stable non-radioactive strontium. In vitro, strontium ranelate increases collagen and non-collagenic proteins synthesis by mature osteoblast enriched cells. The effects of strontium ranelate on bone formation were confirmed as stron...

    journal_title:Current pharmaceutical design

    pub_type: 杂志文章,评审

    doi:10.2174/1381612023393639

    authors: Reginster JY

    更新日期:2002-01-01 00:00:00

  • Role of nitric oxide in gastrointestinal inflammatory and ulcerative diseases: perspective for drugs development.

    abstract::Nitric oxide is a ubiquitous molecule involved in a variety of biological processes. The specific action of NO depends on its enzymatic sources namely neuronal nitric oxide synthase (nNOS), endothelial NOS (eNOS) and inducible NOS (iNOS) and all three isoforms have been localized in the gastrointestinal tract. Constit...

    journal_title:Current pharmaceutical design

    pub_type: 杂志文章,评审

    doi:10.2174/1381612013398491

    authors: Barrachina MD,Panés J,Esplugues JV

    更新日期:2001-01-01 00:00:00

  • Diabetes, cognitive function, and the blood-brain barrier.

    abstract::From a complications standpoint, diabetes mellitus is a disease of the vasculature. Diabetics face a considerably higher risk of developing cardiovascular and cerebrovascular diseases. Both large and small blood vessels are susceptible to alterations from diabetes. Endothelial cell dysfunction associated with small ve...

    journal_title:Current pharmaceutical design

    pub_type: 杂志文章,评审

    doi:10.2174/138161208784705441

    authors: Huber JD

    更新日期:2008-01-01 00:00:00

  • Mobile Health Applications for Prenatal Assessment and Monitoring.

    abstract:BACKGROUND:A mobile health application is an exciting, fast-paced domain that is likely to improve prenatal care. METHODS:In this narrative review, we summarise the use of mobile health applications in this setting with a special emphasis on both the benefits of remote monitoring devices and the potential pitfalls of ...

    journal_title:Current pharmaceutical design

    pub_type: 杂志文章,评审

    doi:10.2174/1381612825666190320140659

    authors: Gyselaers W,Lanssens D,Perry H,Khalil A

    更新日期:2019-01-01 00:00:00